Tri Locum Partners LP Eagle Pharmaceuticals, Inc. Transaction History

Tri Locum Partners LP

  • $387 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$45.82 - $56.9 $5.61 Million - $6.97 Million
-122,503 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$43.79 - $55.78 $1.21 Million - $1.54 Million
27,581 Added 29.06%
122,503 $6.83 Million
Q2 2021

Aug 16, 2021
BUY
$36.86 - $44.5 $3.5 Million - $4.22 Million
94,922 New
94,922 $4.06 Million

Others Institutions Holding EGRX

# of Institutions
78
Shares Held
9.89M
Call Options Held
1.01M
Put Options Held
0
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email